The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics-Reference-Cited by-同舟云学术

The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics

Published:2020 Issue:13 Volume:8 Page:3678-3684
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Daurat Morgane¹²³,Nguyen Christophe⁴⁵⁶²³,Dominguez Gil Sofia⁷⁸⁹¹⁰¹¹,Sol Vincent¹²¹³¹⁴¹⁵¹⁶^ORCID,Chaleix Vincent¹²¹³¹⁴¹⁵¹⁶,Charnay Clarence⁷⁸⁹¹⁰¹¹,Raehm Laurence⁷⁸⁹¹⁰¹¹,El Cheikh Khaled¹²³,Morère Alain⁴⁵⁶²³,Bernasconi Michele¹⁷¹⁸¹⁹²⁰²¹^ORCID,Timpanaro Andrea¹⁷¹⁸¹⁹²⁰²¹^ORCID,Garcia Marcel¹²³,Cunin Frédérique⁷⁸⁹¹⁰¹¹^ORCID,Roessler Jochen¹⁷¹⁸¹⁹²⁰²¹^ORCID,Durand Jean-Olivier⁷⁸⁹¹⁰¹¹^ORCID,Gary-Bobo Magali⁴⁵⁶²³^ORCID

Affiliation:

1. NanoMedSyn Avenue Charles Flahault

2. Montpellier Cedex 05

3. France

4. IBMM

5. UMR 5247 CNRS

6. UM-Faculté de Pharmacie

7. ICGM

8. Univ. Montpellier

9. CNRS

10. ENSCM

11. Montpellier

12. Laboratoire PEIRENE

13. EA 7500

14. Université de Limoges

15. Faculté des Sciences et Techniques

16. 87060 Limoges

17. Division of Pediatric Hematology/Oncology

18. Department of Pediatrics

19. Inselspital

20. Bern University Hospital

21. Department for BioMedical Research (DBMR)

Abstract

Periodic mesoporous organosilica nanoparticles targeted to the mannose 6-phosphate receptor for rhabdomyosarcoma photodynamic therapy using a pulsed laser.

Funder

Agence Nationale de la Recherche

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/D0BM00586J

Reference19 articles.

1. Nab-Paclitaxel Is an Active Drug in Preclinical Model of Pediatric Solid Tumors

2. Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma

3. Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets − sarcoma treatment in progress